Growth Metrics

Armata Pharmaceuticals (ARMP) FCF Margin (2016 - 2018)

Historic FCF Margin for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to 1064.09%.

  • Armata Pharmaceuticals' FCF Margin rose 129990900.0% to 1064.09% in Q4 2018 from the same period last year, while for Dec 2018 it was 1207.89%, marking a year-over-year increase of 92513700.0%. This contributed to the annual value of 708.15% for FY2024, which is 36281200.0% up from last year.
  • Per Armata Pharmaceuticals' latest filing, its FCF Margin stood at 1064.09% for Q4 2018, which was up 129990900.0% from 708.47% recorded in Q3 2018.
  • In the past 5 years, Armata Pharmaceuticals' FCF Margin registered a high of 1064.09% during Q4 2018, and its lowest value of 11935.0% during Q4 2017.
  • Over the past 5 years, Armata Pharmaceuticals' median FCF Margin value was 2929.13% (recorded in 2016), while the average stood at 4146.42%.
  • Per our database at Business Quant, Armata Pharmaceuticals' FCF Margin surged by 815165000bps in 2014 and then plummeted by -90692800bps in 2016.
  • Armata Pharmaceuticals' FCF Margin (Quarter) stood at 3173.27% in 2014, then soared by 42bps to 1849.22% in 2015, then plummeted by -271bps to 6868.18% in 2016, then crashed by -74bps to 11935.0% in 2017, then soared by 109bps to 1064.09% in 2018.
  • Its FCF Margin stands at 1064.09% for Q4 2018, versus 708.47% for Q3 2018 and 667.62% for Q2 2018.